Your browser doesn't support javascript.
loading
MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.
Erice, Oihane; Smith, Michael P; White, Rachel; Goicoechea, Ibai; Barriuso, Jorge; Jones, Chris; Margison, Geoffrey P; Acosta, Juan C; Wellbrock, Claudia; Arozarena, Imanol.
Afiliação
  • Erice O; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom.
  • Smith MP; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom.
  • White R; Edinburgh Cancer Research UK Centre and MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.
  • Goicoechea I; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom.
  • Barriuso J; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom.
  • Jones C; Divisions of Molecular Pathology and Cancer Therapeutics, Institute of Cancer Research, Sutton, United Kingdom.
  • Margison GP; Centre for Occupational and Environmental Health, The University of Manchester, Stopford Building, Manchester, United Kingdom.
  • Acosta JC; Edinburgh Cancer Research UK Centre and MRC Institute of Genetics and Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.
  • Wellbrock C; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom. I.Arozarena@hud.ac.uk Claudia.Wellbrock@manchester.ac.uk.
  • Arozarena I; Manchester Cancer Research Centre, The University of Manchester, Michael Smith Building, Oxford Road, Manchester, United Kingdom. I.Arozarena@hud.ac.uk Claudia.Wellbrock@manchester.ac.uk.
Mol Cancer Ther ; 14(5): 1236-46, 2015 May.
Article em En | MEDLINE | ID: mdl-25777962

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilases de Modificação do DNA / Poli(ADP-Ribose) Polimerases / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Dacarbazina / Enzimas Reparadoras do DNA / Melanoma Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilases de Modificação do DNA / Poli(ADP-Ribose) Polimerases / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Dacarbazina / Enzimas Reparadoras do DNA / Melanoma Idioma: En Ano de publicação: 2015 Tipo de documento: Article